Peritoneal dialysis should be considered as the first line of renal replacement therapy for most ESRD patients.
about
An assessment of the quality of life in hemodialysis patients using the WHOQOL-BREF questionnaire.Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in rats submitted to peritoneal dialysisHaemodialysis: the effects of using the empowerment concept during the development of a mutual-support group in Taiwan.IL-6 promotes epithelial-to-mesenchymal transition of human peritoneal mesothelial cells possibly through the JAK2/STAT3 signaling pathway.
P2860
Peritoneal dialysis should be considered as the first line of renal replacement therapy for most ESRD patients.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Peritoneal dialysis should be ...... herapy for most ESRD patients.
@ast
Peritoneal dialysis should be ...... herapy for most ESRD patients.
@en
Peritoneal dialysis should be ...... herapy for most ESRD patients.
@nl
type
label
Peritoneal dialysis should be ...... herapy for most ESRD patients.
@ast
Peritoneal dialysis should be ...... herapy for most ESRD patients.
@en
Peritoneal dialysis should be ...... herapy for most ESRD patients.
@nl
prefLabel
Peritoneal dialysis should be ...... herapy for most ESRD patients.
@ast
Peritoneal dialysis should be ...... herapy for most ESRD patients.
@en
Peritoneal dialysis should be ...... herapy for most ESRD patients.
@nl
P356
P1433
P1476
Peritoneal dialysis should be ...... herapy for most ESRD patients.
@en
P2093
Burkart JM
P304
P356
10.1159/000046937
P577
2001-01-01T00:00:00Z